Exercise or conversion by Brendan OGrady of 1166 shares of Teva Pharmaceutical subject to Rule 16b-3
| By Brendan OGrady | Macroaxis Story |
Filed transaction by Teva Pharmaceutical Indus officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Transaction by Brendan OGrady
How important is Teva Pharma's Liquidity
Teva Pharma financial leverage refers to using borrowed capital as a funding source to finance Teva Pharma Industries ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Teva Pharma financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Teva Pharma's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Teva Pharma's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Teva Pharma's total debt and its cash.
Teva Pharma Gross Profit
Teva Pharma Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Teva Pharma previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Teva Pharma Gross Profit growth over the last 10 years. Please check Teva Pharma's gross profit and other fundamental indicators for more details.
Another angle On Teva Pharma
Teva Pharmaceutical Industries Limited insider trading alert for exercise of restricted share units by Brendan OGrady, EVP North America Commercial, on March 5, 2019. This event was filed by Teva Pharmaceutical Indus with SEC on 2019-03-05. Statement of changes in beneficial ownership - SEC Form 4. Brendan OGrady is currently serves as executive vice president - north america commercial of Teva Pharmaceutical
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio Architect